Your browser doesn't support javascript.
loading
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.
Mountzios, G; Samantas, E; Senghas, K; Zervas, E; Krisam, J; Samitas, K; Bozorgmehr, F; Kuon, J; Agelaki, S; Baka, S; Athanasiadis, I; Gaissmaier, L; Elshiaty, M; Daniello, L; Christopoulou, A; Pentheroudakis, G; Lianos, E; Linardou, H; Kriegsmann, K; Kosmidis, P; El Shafie, R; Kriegsmann, M; Psyrri, A; Andreadis, C; Fountzilas, E; Heussel, C-P; Herth, F J; Winter, H; Emmanouilides, C; Oikonomopoulos, G; Meister, M; Muley, T; Bischoff, H; Saridaki, Z; Razis, E; Perdikouri, E-I; Stenzinger, A; Boukovinas, I; Reck, M; Syrigos, K; Thomas, M; Christopoulos, P.
Afiliação
  • Mountzios G; Fourth Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece. Electronic address: gmountzios@gmail.com.
  • Samantas E; Second Oncology Department, Metropolitan Hospital, Pireaus, Athens, Greece.
  • Senghas K; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Zervas E; 7th Pneumonology Department 'Sotiria' Hospital, Athens, Greece.
  • Krisam J; Institute of Medical Biometry and Statistics, Heidelberg University Hospital, Heidelberg, Germany.
  • Samitas K; Department of Medical Oncology, University of Irakleion School of Medicine, Iraklion, Greece.
  • Bozorgmehr F; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Kuon J; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Agelaki S; Department of Medical Oncology, University of Irakleion School of Medicine, Iraklion, Greece.
  • Baka S; Department of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece.
  • Athanasiadis I; Department of Medical Oncology, 'Mitera' Hospital, Athens, Greece.
  • Gaissmaier L; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Elshiaty M; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Daniello L; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Christopoulou A; Department of Medical Oncology, General Hospital of Patras 'Agios Andreas', Patras, Greece.
  • Pentheroudakis G; Department of Medical Oncology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Lianos E; Department of Medical Oncology, 'Metaxa' Cancer Hospital, Pireaus, Greece.
  • Linardou H; Fourth Oncology Department, Metropolitan Hospital, Pireaus, Athens, Greece.
  • Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Kosmidis P; Second Oncology Department, 'Hygeia' Hospital, Athens, Greece.
  • El Shafie R; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kriegsmann M; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Psyrri A; Department of Medical Oncology, 'Attikon' University Hospital, Athens, Greece.
  • Andreadis C; Third Department of Medical Oncology, 'Theageneion' Cancer Hospital, Thessaloniki, Greece.
  • Fountzilas E; Department of Medical Oncology, 'Euromedica' Clinic, Thessaloniki, Greece.
  • Heussel CP; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Herth FJ; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Winter H; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Emmanouilides C; Department of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece.
  • Oikonomopoulos G; Second Oncology Department, Metropolitan Hospital, Pireaus, Athens, Greece.
  • Meister M; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Muley T; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Bischoff H; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Saridaki Z; Department of Medical Oncology, 'Asclepius' Clinic, Iraklion, Greece.
  • Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Perdikouri EI; Department of Medical Oncology, 'Achilopouleio' General Hospital of Volos, Volos, Greece.
  • Stenzinger A; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Boukovinas I; Department of Medical Oncology, 'Bioclinica' Hospital, Thessaloniki, Greece.
  • Reck M; LungenClinic Großhansdorf GmbH, Großhansdorf, Germany; Airway Research Center North, German Center for Lung Research, Großhansdorf, Germany.
  • Syrigos K; Department of Medical Oncology, Sotiria General Hospital of Athens, Athens, Greece.
  • Thomas M; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Christopoulos P; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany. Electronic address: petros.christopoulos@med.uni-heidelberg.de.
ESMO Open ; 6(5): 100254, 2021 10.
Article em En | MEDLINE | ID: mdl-34481329
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article